Mendelian randomization does not support the effects of G CSF on decompensated liver disease
Saved in:
Main Authors: | Liling Li, Hui Wang, Hong Wang, Jinchang Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2025-07-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-2025-0172.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Colonic growth factors (G-CSF, GM-CSF) and chemokines (MCP-1, MIP-1β) in severe ulcerative colitis
by: Yevgeny A. Konovich, et al.
Published: (2018-08-01) -
Mendelian randomization analysis of CpG methylation and immune phenotypes in epithelial ovarian cancer outcomes
by: Jiawei Li, et al.
Published: (2025-12-01) -
M-CSF Protects Against Ulcerative Colitis via Aconitate: Mendelian Randomization and Experimental Evidence
by: Zhang Y, et al.
Published: (2025-07-01) -
Association of behavioral factors, liver function and NAFLD: Bayesian Mendelian randomization
by: Lei Pu, et al.
Published: (2025-06-01) -
Genetic analysis of the correlation between GLP1 action and metabolic liver disease: Insights from Mendelian randomization analysis
by: Zhiqiang Ma, et al.
Published: (2025-08-01)